Appeals Court Rejects Insurers Risk Corridors Claims

M
Mintz

Contributor

Mintz is a general practice, full-service Am Law 100 law firm with more than 600 attorneys. We are headquartered in Boston and have additional US offices in Los Angeles, Miami, New York City, San Diego, San Francisco, and Washington, DC, as well as an office in Toronto, Canada.
On Thursday June 14, 2018, the US Court of Appeals for the Federal Circuit ruled against two health plans seeking risk corridors payments from the federal government.
United States Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

On Thursday June 14, 2018, the US Court of Appeals for the Federal Circuit ruled against two health plans seeking risk corridors payments from the federal government. A more detailed background on the program and pending litigation is available in my prior post  hereThe risk corridors program was essentially a three-year program created to help stabilize premiums during the ACA's initial implementation period. The program required profitable insurers to pay funds into the program and used these funds to subsidize insurers with higher medical claims. As noted in my previous post, Congress subsequently inserted riders in appropriations legislation which made the risk corridor program budget neutral—meaning the program would not pay out more money than it received. As a result, an estimated $12.3 billion in risk corridors receipts were never paid out to insurers.

Insurers had successfully convinced the lower court that the subsequent Congressional riders restricting the program as budget neutral did not vitiate the federal government's statutory duty to make risk corridors payments in full, and that in the alternative, the risk corridors legislation created an implied-in-fact contract for full payment of the risk corridors payments. However, the Appeals Court rejected both arguments, holding that HHS has no obligation to make risk corridor payments to insurers under the ACA because those subsequent congressional riders "suspended the government's obligation in each year of the program through intent," and that the "[risk corridors] legislation and subsequent regulation did not create a contract promising the full amount of risk corridors payments."

A copy of the relevant decision is available here. As noted in the last post, despite this decision, it is unlikely that the battle over the risk corridors will be over any time soon. In a future post, I will expand on the decision and discuss its implications.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

Appeals Court Rejects Insurers Risk Corridors Claims

United States Food, Drugs, Healthcare, Life Sciences

Contributor

Mintz is a general practice, full-service Am Law 100 law firm with more than 600 attorneys. We are headquartered in Boston and have additional US offices in Los Angeles, Miami, New York City, San Diego, San Francisco, and Washington, DC, as well as an office in Toronto, Canada.
See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More